High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,658,270
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TBPH |
Theravance Biopharma, Inc.
|
Director
Other
|
2025-11-26 | $142,100 | M | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
BROSHY ERAN
• Director
10b5-1 SellΔOwn -18.9%
2025-11-26
$590,020x2
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Director
10b5-1 SellΔOwn -18.9%
|
2025-11-26 | $590,020x2 | S | Form 4 |
| TBPH |
Theravance Biopharma, Inc.
|
Director
Other
|
2025-11-11 | $142,100 | M | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
BROSHY ERAN
• Director
10b5-1 SellΔOwn -23.2%
2025-11-11
$1,068,250Largex3
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Director
10b5-1 SellΔOwn -23.2%
|
2025-11-11 | $1,068,250Largex3 | S | Form 4 |